Search company, investor...

Predict your next investment

Varian Medical Systems company logo
Corporation
HEALTHCARE | Medical Devices & Equipment / Therapeutic Devices
varian.com

Investments

17

Portfolio Exits

7

Partners & Customers

10

Service Providers

1

About Varian Medical Systems

Varian Medical Systems (NYSE: VAR) manufactures medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers, and medical oncology practices. Varian is a supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications, and X-ray imaging products for cargo screening and industrial inspection.

Headquarters Location

3100 Hansen Way

Palo Alto, California, 94304,

United States

650-493-4000

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Expert Collections containing Varian Medical Systems

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Varian Medical Systems in 1 Expert Collection, including Conference Exhibitors.

C

Conference Exhibitors

5,302 items

Research containing Varian Medical Systems

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Varian Medical Systems in 1 CB Insights research brief, most recently on Mar 21, 2022.

Latest Varian Medical Systems News

Gamma knife Market Is Expected to Register a CAGR of 5.20 % During the Forecast Period, 2023–2032

Feb 20, 2024

Gamma knife Market Is Expected to Register a CAGR of 5.20 % During the Forecast Period, 2023–2032 Research Reports Feb 19, 2024 Global Gamma Knife Market Research Report: Information By Disease Indication (Brain Metastasis, Cancer, Arteriovenous Malformation, Trigeminal Neuralgia, Others), By Anatomy (Head, Neck, Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032 According to MRFR analysis, the global Gamma knife Market is expected to register a CAGR of 5.20 % from 2023 to 2032. The Gamma Knife market has witnessed substantial growth in recent years, fueled by the increasing incidence of brain tumors, trigeminal neuralgia, and arteriovenous malformations. The market is characterized by the dominance of established players such as Elekta AB, Varian Medical Systems, and Huiheng Medical, who continue to invest in research and development to enhance their product offerings. Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/19189 One of the key factors driving the market is the growing preference for non-invasive procedures. Gamma Knife radiosurgery allows precise targeting of lesions or tumors in the brain without the need for surgical incisions. This minimally invasive approach results in shorter recovery times, reduced hospital stays, and improved patient outcomes. Recent advancements in Gamma Knife technology have focused on improving treatment accuracy, reducing treatment time, and expanding the range of treatable conditions. The integration of advanced imaging technologies, such as magnetic resonance imaging (MRI) and positron emission tomography (PET), has allowed for better treatment planning and targeting. Segmentation The global gamma knife market has been segmented based on Disease Indication, and Anatomy. On the basis of Disease Indication, the market is segmented into Brain Metastasis, Cancer, Arteriovenous Malformation, Trigeminal Neuralgia, others. The Cancer segment dominated the market 2022. Increased healthcare spending worldwide allows for greater adoption of advanced medical technologies like the Gamma Knife. Based on Anatomy, the global gamma knife market has been segmented into Head, Neck, others. The Head category generated the most revenue in 2022. The aging population is more prone to neurological conditions, leading to a growing demand for precise and effective treatment options. Key Players MRFR recognizes the following companies as the key players in the global gamma knife market— Elekta, Varian Medical Systems, Huiheng Medical, Inc., Akesis, Inc, MASEP Medical Science Technology Development (Shenzhen) Co., Ltd., American Radiosurgery Inc., Panacea Medical Technologies Pvt. Ltd., Nordion (Canada) Inc., Accuray Incorporated, Hitachi, Ltd. Regional Analysis The global gamma knife market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe Gamma knife market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The Gamma knife market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World Gamma knife market comprises of Middle East, Africa, and Latin America. The largest market share for Gamma knife was maintained by the North American regional sector. In North America, the Gamma Knife marketplace exhibits sturdy increase driven by means of a mixture of technological advancements, increasing occurrence of neurological issues, and a well-hooked up healthcare infrastructure. The location boasts a high adoption charge of innovative clinical technologies, and with a developing ageing populace, there may be a heightened demand for precise and non-invasive remedies like Gamma Knife therapy. Moreover, strategic collaborations among healthcare institutions and industry leaders make a contribution to the enlargement of Gamma Knife applications, making it a distinguished player within the neurosurgical landscape. Browse In-depth Market Research Report (128 Pages) on Gamma knife: https://www.marketresearchfuture.com/reports/gamma-knife-market-19189 Moreover, In Europe, the Gamma Knife market is marked through a consistent upward push in demand, supported through favorable government regulations, research tasks, and a growing consciousness of advanced medical remedies. European nations with robust healthcare systems are making an investment in Gamma Knife technology to cope with the growing incidence of mind disorders and improve patient outcomes. The aggressive landscape in Europe is characterised by using the presence of key market gamers imparting modern solutions, contributing to the general increase of the Gamma Knife marketplace inside the area. Discover More Research Reports on Healthcare Industry by Market Research Future: Healthcare Cloud Computing Market Research Report Information By Application (Non-Clinical Information Systems and Clinical Information Systems), By Deployment (Private Cloud, Public Cloud, and Hybrid Cloud), By End User (Healthcare Providers and Healthcare Players), By Service (IaaS, SaaS, and PaaS) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032 Electric Wheelchair Market Research Report Information By Types (Center Wheel Drive Chair, Front Wheel Drive Chair, and Rear Wheel Drive Chair), By End-users (Home Care Settings and Hospitals & Clinics), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032 Healthcare Contract Manufacturing Market Research Report Information by Type (Sterile and Non-Sterile), Service Type (Pharmaceutical Contract Manufacturing and Medical Device Contract Manufacturing), Industry (Pharmaceutical Industry, Medical Device Industry and Biopharmaceutical Industry) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) – Forecast till 2030 Women Healthcare Market Research Report Information By Indication(Postmenopausal Osteoporosis, Infertility, Reproductive Health Management, Polycystic Ovary Syndrome, Gynecologic Cancer, And others), By Diagnosis and Treatment (Bone Densitometry, Diagnostic Imaging Tests, Biopsies, Ovulation Testing, And Others), By Treatment (Therapeutics, Surgeries, And Others), By End Users (Hospitals & Clinics, Gynecology Centers, Research Institutes, And Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast DNA Sequencing Market Research Report Information By Product (Consumable, Instrument, and Service), By Application (Diagnostics, Biomarkers & Cancer, Reproductive Health, Personalized Medicine, and Forensics), By Technology (Semiconductor Sequencing, Sequencing by Ligation, and Pyrosequencing), By End-User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2030. About Market Research Future: Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions. Follow Us: LinkedIn | Twitter Tags: Gamma Knife market trends, Gamma Knife market, Gamma Knife Market Share, Gamma Knife Market Size See Campaign: https://www.marketresearchfuture.com/reports/gamma-knife-market-19189 Contact Information: Market Research Future (Part of Wantstats Research and Media Private Limited) 99 Hudson Street, 5Th Floor New York, NY 10013 United States of America +1 628 258 0071 (US) +44 2035 002 764 (UK) Email: sales@marketresearchfuture.com Website: https://www.marketresearchfuture.com Tags:

Varian Medical Systems Investments

17 Investments

Varian Medical Systems has made 17 investments. Their latest investment was in Bendit Technologies as part of their Series B on March 25, 2021.

CBI Logo

Varian Medical Systems Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

3/25/2021

Series B

Bendit Technologies

Yes

1

11/10/2020

Convertible Note

COTA

$10M

No

6

6/8/2020

Series C - II

HistoSonics

$40M

No

6

5/6/2020

Series C

Subscribe to see more

$99M

Subscribe to see more

10

1/1/2020

Corporate Minority

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/25/2021

11/10/2020

6/8/2020

5/6/2020

1/1/2020

Round

Series B

Convertible Note

Series C - II

Series C

Corporate Minority

Company

Bendit Technologies

COTA

HistoSonics

Subscribe to see more

Subscribe to see more

Amount

$10M

$40M

$99M

$99M

New?

Yes

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

6

6

10

10

Varian Medical Systems Portfolio Exits

7 Portfolio Exits

Varian Medical Systems has 7 portfolio exits. Their latest portfolio exit was GRAIL on August 18, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

8/18/2021

Acquired

$99M

36

6/26/2020

IPO

Subscribe to see more

$99M

Subscribe to see more

10

12/12/2018

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

9/6/2018

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

1/30/2017

IPO

Subscribe to see more

$99M

Subscribe to see more

0

Date

8/18/2021

6/26/2020

12/12/2018

9/6/2018

1/30/2017

Exit

Acquired

IPO

Acquired

Acquired

IPO

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

36

10

10

10

0

Varian Medical Systems Acquisitions

22 Acquisitions

Varian Medical Systems acquired 22 companies. Their latest acquisition was Aspekt Solutions on September 26, 2023.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

9/26/2023

Debt

$99M

$0.25M

Acquired

3

7/2/2019

$99M

Acquired Unit

1

6/12/2019

$99M

Acquired

1

6/10/2019

Subscribe to see more

$99M

Subscribe to see more

10

6/10/2019

Other Venture Capital

Subscribe to see more

$99M

$99M

Subscribe to see more

10

Date

9/26/2023

7/2/2019

6/12/2019

6/10/2019

6/10/2019

Investment Stage

Debt

Other Venture Capital

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$0.25M

$99M

Note

Acquired

Acquired Unit

Acquired

Subscribe to see more

Subscribe to see more

Sources

3

1

1

10

10

Varian Medical Systems Partners & Customers

10 Partners and customers

Varian Medical Systems has 10 strategic partners and customers. Varian Medical Systems recently partnered with Alameda Healthcare Group on November 11, 2023.

Date

Type

Business Partner

Country

News Snippet

Sources

11/13/2023

Partner

Egypt

Alameda Healthcare Group and Varian sign MoU

Commenting on the partnership , Dr. Fahad Khater , Chairman of Alameda Healthcare Group said , `` Our collaboration with Varian stands as a resounding testament to our commitment to elevating the standard of healthcare in Egypt .

1

2/17/2023

Client

Canada

Varian Collaborating with Nova Scotia Health to Transform Cancer Care

PALO ALTO , Calif. , Feb. 17 , 2023 / PRNewswire / -- Varian , a Siemens Healthineers company , has entered into an agreement with Nova Scotia Health to lead the digital transformation of the health system 's comprehensive oncology service line .

2

2/17/2023

Client

Canada

Nova Scotia Health Innovation Hub. Nova Scotia Health launches first-in-Canada technology that brings together oncology information in real time

`` This agreement with Nova Scotia Health Innovation Hub reflects our commitment to collaborating with providers to streamline workflows and embed digitization , quality , and simplicity into every step of the care journey , '' said Andrew Shogan , President of Multi-Disciplinary Oncology at Varian .

1

5/11/2022

Partner

Canada, and United States

Subscribe to see more

Subscribe to see more

10

5/5/2022

Partner

Australia

Subscribe to see more

Subscribe to see more

10

Date

11/13/2023

2/17/2023

2/17/2023

5/11/2022

5/5/2022

Type

Partner

Client

Client

Partner

Partner

Business Partner

Country

Egypt

Canada

Canada

Canada, and United States

Australia

News Snippet

Alameda Healthcare Group and Varian sign MoU

Commenting on the partnership , Dr. Fahad Khater , Chairman of Alameda Healthcare Group said , `` Our collaboration with Varian stands as a resounding testament to our commitment to elevating the standard of healthcare in Egypt .

Varian Collaborating with Nova Scotia Health to Transform Cancer Care

PALO ALTO , Calif. , Feb. 17 , 2023 / PRNewswire / -- Varian , a Siemens Healthineers company , has entered into an agreement with Nova Scotia Health to lead the digital transformation of the health system 's comprehensive oncology service line .

Nova Scotia Health Innovation Hub. Nova Scotia Health launches first-in-Canada technology that brings together oncology information in real time

`` This agreement with Nova Scotia Health Innovation Hub reflects our commitment to collaborating with providers to streamline workflows and embed digitization , quality , and simplicity into every step of the care journey , '' said Andrew Shogan , President of Multi-Disciplinary Oncology at Varian .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

2

1

10

10

Varian Medical Systems Service Providers

1 Service Provider

Varian Medical Systems has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Corporate Majority - P2P

Investment Bank

Financial Advisor

Service Provider

Associated Rounds

Corporate Majority - P2P

Provider Type

Investment Bank

Service Type

Financial Advisor

Partnership data by VentureSource

Varian Medical Systems Team

7 Team Members

Varian Medical Systems has 7 team members, including current Chief Medical Officer, Joseph R. Steele.

Name

Work History

Title

Status

Joseph R. Steele

Boston Scientific, and Covalent Radiology

Chief Medical Officer

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Joseph R. Steele

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Boston Scientific, and Covalent Radiology

Title

Chief Medical Officer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Compare Varian Medical Systems to Competitors

Carevive Systems Logo
Carevive Systems

Carevive Systems operates as an oncology-focused health technology company. The company's platform enables providers to monitor patient symptoms remotely using electronic patient-reported outcomes (ePROs) and to provide timely interventions that improve survival outcomes and patient quality of life. It was founded in 2013 and is based in Miami, Florida.

Navigating Cancer Logo
Navigating Cancer

Navigating Cancer is a digital health company that operates in the healthcare sector, with a specific focus on oncology care. The company offers digital solutions such as electronic patient reported outcomes, digital triage, and patient engagement tools, all aimed at improving health management, reducing costs, and enhancing the quality of life for cancer patients. These services primarily cater to the healthcare industry, particularly oncology care providers. It was founded in 2008 and is based in Seattle, Washington.

MVision AI Logo
MVision AI

MVision AI develops automatic segmentation and contouring software. The software integrates with hospital systems to provide contours of various critical structures. The company was founded in 2017 and is based in Helsinki, Finland.

TheraPanacea Logo
TheraPanacea

TheraPanacea is a medical technology company that focuses on the healthcare sector, specifically in the field of cancer care. The company offers AI-based software solutions for more efficient and precise cancer treatment planning and delivery, including adaptive radiotherapy and automatic delineation. TheraPanacea primarily serves the healthcare industry, with a particular emphasis on cancer centers and pharmaceutical companies. It was founded in 2017 and is based in Paris, France.

Brainlab Logo
Brainlab

Brainlab is a pioneer in digital medical technology, operating in the healthcare sector. The company's main offerings include software-driven medical solutions that digitize, automate, and optimize clinical workflows for various surgical procedures and radiotherapy. These solutions primarily cater to physicians, medical professionals, and their patients. It was founded in 1989 and is based in Munich, Germany.

A
Abbott Diabetes Care

Abbott Diabetes Care focuses on diabetes management in the healthcare sector. The company's main offerings include glucose monitoring products to help patients and healthcare professionals measure, track, and analyze glucose levels. It primarily serves the healthcare industry. It was founded in 1995 and is based in Alameda, California.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.